The Latest Breaking News from Vertex

Futures fell as Fitch downgraded the U.S. debt rating. AMD and ELF Beauty were big earnings movers late

Vertex Pharmaceuticals faces numerous catalysts this year and next, an analyst said Wednesday. And VRTX stock popped.

Whether you’re a soldier or a civvie, these timepieces are built for any situation

The FDA could approve Crispr Therapeutics' gene-edited sickle cell treatment as early as December. In response, CRSP stock surged Friday.

Vertex is the IBD Stock Of The Day as the maker of corporate tax compliance software shows its resilience in an unstable market.

Vertexs has been present in South Africa as the young patient copes with the high cost of the medication.

Vertex Pharmaceuticals retained its full-year outlook and beat quarterly views, pushing VRTX stock higher early Tuesday.

The new, self-custodial DEX will offer high-speed spot and derivatives trading.

Vertex enters into a partnership to develop novel small molecules. Shares have gained 15% this year.

Medical stocks are holding up amid economic and market uncertainty.

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…